CRISPR Therapeutics has presented preclinical data showing that its investigational therapy CTX460 can correct the SERPINA1 Z (E342K) mutation...
Precision BioSciences presented encouraging early clinical results from its PBGENE-HBV programme at the 6th International Coalition to Eliminate HBV...